RemSleep Holdings (RMSL) Enterprise Value Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RemSleep Holdings | - | - | -7,636.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54.59% |
| Sep 30, 2025 | 35.68% |
| Jun 30, 2025 | 40.47% |
| Mar 31, 2025 | 29.13% |
| Dec 31, 2024 | 34.31% |
| Sep 30, 2024 | 40.87% |
| Jun 30, 2024 | 35.44% |
| Mar 31, 2024 | 50.12% |
| Dec 31, 2023 | 60.96% |
| Sep 30, 2023 | 58.15% |
| Jun 30, 2023 | 54.78% |
| Mar 31, 2023 | 63.51% |
| Dec 31, 2022 | 45.56% |
| Sep 30, 2022 | 8.59% |
| Jun 30, 2022 | -582.08% |
| Mar 31, 2022 | -2,426.91% |
| Dec 31, 2021 | -2,862.14% |
| Sep 30, 2021 | -2,341.13% |
| Jun 30, 2021 | -635.01% |
| Mar 31, 2021 | 37.37% |
| Dec 31, 2020 | 4.47% |
| Sep 30, 2020 | 4.77% |
| Jun 30, 2020 | 73.74% |
| Mar 31, 2020 | -471.94% |
| Dec 31, 2019 | -618.59% |
| Sep 30, 2019 | -148.29% |
| Jun 30, 2019 | -32,768.54% |
| Mar 31, 2019 | 15.13% |
| Dec 31, 2018 | -726.22% |
| Sep 30, 2018 | -74,363.64% |
| Mar 31, 2014 | 77.43% |
| Sep 30, 2013 | 100.01% |
| Jun 30, 2013 | 95.82% |
| Mar 31, 2013 | 81.46% |
| Dec 31, 2012 | 92.42% |
| Sep 30, 2012 | 66.87% |
| Jun 30, 2012 | 64.87% |
| Dec 31, 2011 | 41.31% |